Says “I don’t think the Street” has adjusted yet and that “they should have a look on it.” The company says the rebates that Pfizer (PFE) will be asked to be in Q3 and Q4 “will probably be less” and that the rebates it will be asked to pay in Q1 and Q2 “will be higher.” Comments taken from TD Cowen’s 45th Annual Health Care Conference.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PFE:
- Salesforce CEO Benioff says ‘this was the best quarter we ever had’
- Biotech Alert: Searches spiking for these stocks today
- Eli Lilly (LLY) Commits $27B to U.S. Days after Trump Told Big Pharma to Bring Production Home or Face Tariffs
- Pfizer price target lowered to $30 from $32 at Bernstein
- Apple to invest $500B in U.S., Domino’s reports downbeat Q4: Morning Buzz